Liquid Biopsies Replacing Tissue-based Tests and Improving Treatment
Liquid biopsies improve access to treatment options for many cancers and may replacing tissue tests & diagnostic imaging
Tumor Mutational Burden Predicts for Response to Immuotherapy in NSCLC
Research suggests that tumor mutational burden assessment can help predict response to immunotherapy in NSCLC.
Amivantamab Treatment of EGFR Positive Non-Small Cell Lung Cancer
Amivantamab targets Non-Small Cell Lung Cancer with cancer causing EGFR Exon 20 Insertion Mutations
Lung Cancer
Lung Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. Lung Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Lung Cancer Overviews
Liquid Biopsies Replacing Tissue-based Tests and Improving Treatment
Liquid biopsies improve access to treatment options for many cancers and may replacing tissue tests & diagnostic imaging
Overview of Small Cell Lung Cancer
Symptoms, Diagnosis and Treatment of Small Cell Lung Cancer
Screening For Lung Cancer - What You Need to Know
What is the evidence and current recommendations for lung cancer screening - guidelines updated March 2021.
Solitary Pulmonary Nodules and Granulomas
A single nodule may represent cancer or any number of less lethal conditions.
Lung Cancer Treatment & Management
Tumor Mutational Burden Predicts for Response to Immuotherapy in NSCLC
Research suggests that tumor mutational burden assessment can help predict response to immunotherapy in NSCLC.
Amivantamab Treatment of EGFR Positive Non-Small Cell Lung Cancer
Amivantamab targets Non-Small Cell Lung Cancer with cancer causing EGFR Exon 20 Insertion Mutations
Precision Cancer Medicines & Immunotherapy for Lung Cancer
Keep up with the growing number of precision medicines targeting specific mutations in lung cancer.
Mobocertinib Treatment for Non-Small Cell Lung Cancer with exon 20 Mutations
FDA grants breakthrough therapy status to Mobocertinib for treatment of patients with NSCLC and exon 20 mutations.
Lung Cancer Survivorship
Variety of Veggies and Fruits May Help Prevent Lung Cancer
Research suggests diet and nutrition play in role in reducing the risk of lung cancer.
Does Air Pollution Cause Lung Cancer?
The WHO classifies air pollution as a carcinogen & ample evidence is emerging on it overall negative health consequences
CancerConnect - November is Lung Cancer Awareness Month
Development of precision cancer medicines, immunotherapy, genomic testing are proceeding with great speed - Stay Current
